World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01917422
Date of registration: 28/09/2012
Prospective Registration: No
Primary sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Public title: Clinical Specimens Testing Program of Dengue Antigen Detection Reagents
Scientific title: Clinical Specimens Testing Program of Dengue Antigen Detection Reagents
Date of first enrolment: July 2012
Target sample size: 195
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01917422
Study type:  Observational
Study design:  Observational Model: Case Control  
Phase:  N/A
Countries of recruitment
Taiwan
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:A total of 95 cases and 100 controls (suspected cases(>50 %) and normal
subjects) are expected to enroll.

1. Case group: adults having a medical visit or admission due to dengue / dengue
hemorrhagic fever / dengue shock syndrome, and medical care of by (defined by CDC).
Any of the following positive test results for the case of 100 adults.

1. clinical specimens (blood) isolated and identified dengue virus.

2. clinical specimens positive for molecular detection of nucleic acids.

3. serological antigen (referring to non-structural proteins of dengue virus
non-structural protein 1, NS1) testing positive (based on the test of Bio-Rad
DENGUE NS1 Ag STRIP).

4. paired serum (restored period and acute phase), the dengue virus specific
immunoglobulin M or immunoglobulin G antibodies or negative or ? 4 times
increase.

2. Suspected cases: adults having medical visits or admissions due to infectious
disease, but their NS1 (based on the test of Bio-Rad DENGUE NS1 Ag STRIP),
immunoglobulin G,immunoglobulin M, real time-Polymerase chain reaction testing were
negative.

3. Control group: adults without having medical visits or admissions due to Fever. -
Exclusion Criteria:non-adult case -



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Dengue Fever
Intervention(s)
Primary Outcome(s)
Clinical specimens testing program of dengue antigen detection reagents [Time Frame: one year]
Secondary Outcome(s)
Secondary ID(s)
KMUHIRB-2012-03-14(II)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history